SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
08-Oct-24 4:15 PM View: | In8bio, Inc. (INAB) | 04-Oct-24 | Grant | 253,164 | -- | -- | 68% 369.73K to 622.89K | |
15-Dec-23 8:18 AM View: | In8bio, Inc. (INAB) | 13-Dec-23 | Grant | 81,967 | -- | -- | 28% 287.76K to 369.73K | |
18-Aug-22 4:07 PM View: | In8bio, Inc. (INAB) | 16-Aug-22 | Private Purchase | 105,263 | $1.90 | $200,000.00 | 58% 182.5K to 287.76K | |
30-Jan-15 9:28 AM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 29-Jan-15 | Disposition (other) | 25,000 | $7.31 | $182,650.00 | (100%) 25.0K to 0 | |
22-May-14 4:04 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 21-May-14 | Grant | 5,000 | -- | -- | 25% 20.0K to 25.0K | |
03-May-13 2:01 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 01-May-13 | Grant | 5,000 | -- | -- | 33% 15.0K to 20.0K | |
13-Mar-13 9:26 PM View: | Epocrates, Inc. (EPOC) | 12-Mar-13 | Disposition | 38,729 | -- | -- | (100%) 38.73K to 0 | |
22-Jun-12 12:41 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 21-Jun-12 | Grant | 5,000 | -- | -- | 50% 10.0K to 15.0K | |
01-Mar-12 5:01 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 28-Feb-12 | Market Purchase | 10,000 | $20.10 | $200,998.00 | 100% 0 to 10.0K | 71% |
09-Dec-11 4:48 PM View: | Epocrates, Inc. (EPOC) | 07-Dec-11 | Grant | 20,595 | -- | -- | 82% 25.0K to 45.59K | |
12-Sep-11 4:38 PM View: | Ocuphire Pharma, Inc. (OCUP) | 09-Sep-11 | Market Purchase | 80,000 | $1.22 | $97,570.70 | 114% 70.0K to 150.0K | (99%) |
12-Sep-11 4:38 PM View: | Ocuphire Pharma, Inc. (OCUP) | 08-Sep-11 | Market Purchase | 45,000 | $1.10 | $49,284.40 | 180% 25.0K to 70.0K | (99%) |
08-Sep-11 5:54 PM View: | Ocuphire Pharma, Inc. (OCUP) | 07-Sep-11 | Market Purchase | 5,000 | $1.04 | $5,200.00 | 25% 20.0K to 25.0K | (99%) |
09-Sep-11 2:28 PM View: | Epocrates, Inc. (EPOC) | 07-Sep-11 | Market Purchase | 14,568 | $9.78 | $142,431.00 | 140% 10.43K to 25.0K | 20% |
08-Sep-11 5:54 PM View: | Ocuphire Pharma, Inc. (OCUP) | 06-Sep-11 | Market Purchase | 20,000 | $0.95 | $18,922.50 | 100% 0 to 20.0K | (99%) |
08-Sep-11 3:02 PM View: | Epocrates, Inc. (EPOC) | 06-Sep-11 | Market Purchase | 10,432 | $9.58 | $99,972.00 | 100% 0 to 10.43K | 22% |
27-Aug-09 3:52 PM View: | Noven Pharmaceuticals Inc. (NOVNE.PK) | 27-Aug-09 | Disposition (change in control) | 183,333 | $16.50 | $3,024,990.00 | (100%) 183.33K to 0 | < 1% |
21-Aug-09 5:12 PM View: | Noven Pharmaceuticals Inc. (NOVNE.PK) | 20-Aug-09 | Disposition (change in control) | 111,667 | $16.50 | $1,842,510.00 | (38%) 295.0K to 183.33K | < 1% |
02-Sep-08 5:04 PM View: | Noven Pharmaceuticals Inc. (NOVNE.PK) | 29-Aug-08 | Market Purchase | 20,000 | $12.39 | $247,783.00 | 7% 275.0K to 295.0K | 36% |
15-May-08 4:31 PM View: | Noven Pharmaceuticals Inc. (NOVNE.PK) | 14-May-08 | Market Purchase | 20,000 | $9.79 | $195,800.00 | 8% 255.0K to 275.0K | 72% |
15-May-08 4:31 PM View: | Noven Pharmaceuticals Inc. (NOVNE.PK) | 13-May-08 | Market Purchase | 5,000 | $9.81 | $49,071.90 | 2% 250.0K to 255.0K | 71% |
01-May-08 4:09 PM View: | Noven Pharmaceuticals Inc. (NOVNE.PK) | 29-Apr-08 | Grant | 250,000 | -- | -- | 100% 0 to 250.0K |